Total Payments
$1,536
2024 Payments
$514.84
Companies
9
Transactions
74
Medicare Patients
515
Medicare Billing
$43,771
Payment Breakdown by Category
Food & Beverage$1,438 (93.6%)
Education$97.64 (6.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,438 | 70 | 93.6% |
| Education | $97.64 | 4 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Insmed, Inc. | $333.67 | 16 | $0 (2024) |
| ABBVIE INC. | $311.43 | 12 | $0 (2024) |
| Merck Sharp & Dohme LLC | $307.06 | 19 | $0 (2024) |
| La Jolla Pharmaceutical Company | $262.42 | 10 | $0 (2024) |
| Gilead Sciences, Inc. | $100.50 | 6 | $0 (2024) |
| ViiV Healthcare Company | $92.42 | 4 | $0 (2024) |
| Shionogi Inc | $77.79 | 4 | $0 (2024) |
| Melinta Therapeutics, LLC | $28.01 | 2 | $0 (2022) |
| NESTLE HEALTHCARE NUTRITION INC. | $22.28 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $514.84 | 27 | Insmed, Inc. ($151.31) |
| 2023 | $489.82 | 19 | ABBVIE INC. ($178.61) |
| 2022 | $385.63 | 19 | La Jolla Pharmaceutical Company ($149.46) |
| 2021 | $145.29 | 9 | La Jolla Pharmaceutical Company ($71.35) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/03/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Respiratory | ||||||
| 09/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $1.30 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $18.55 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/29/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Respiratory | ||||||
| 06/20/2024 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 06/13/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug), RECARBRIO | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/30/2024 | ABBVIE INC. | DALVANCE (Drug), TEFLARO, AVYCAZ | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/20/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $7.68 | General |
| Category: Respiratory | ||||||
| 05/09/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Infections and Infectious Diseases | ||||||
| 04/18/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $31.88 | General |
| Category: HIV | ||||||
| 03/22/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.85 | General |
| 03/21/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/06/2024 | Insmed, Inc. | Arikayce (Drug) | Education | In-kind items and services | $0.94 | General |
| Category: Respiratory | ||||||
| 02/29/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/22/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: ANTI-INFECTIVE | ||||||
| 02/15/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $16.45 | General |
| 02/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 150 | 248 | $46,712 | $13,609 |
| 2022 | 4 | 211 | 380 | $62,141 | $18,683 |
| 2021 | 3 | 135 | 237 | $31,992 | $10,681 |
| 2020 | 1 | 19 | 31 | $2,635 | $799.18 |
Total Patients
515
Total Services
896
Medicare Billing
$43,771
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 133 | $21,980 | $6,622 | 30.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 44 | $10,592 | $3,364 | 31.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 37 | 56 | $11,960 | $3,213 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 15 | $2,180 | $409.44 | 18.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 92 | 203 | $29,967 | $9,223 | 30.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 52 | 99 | $13,833 | $3,876 | 28.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 42 | 53 | $11,334 | $3,494 | 30.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 25 | $7,007 | $2,090 | 29.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 66 | 125 | $18,658 | $5,889 | 31.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 52 | 81 | $9,745 | $3,393 | 34.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2021 | 17 | 31 | $3,589 | $1,398 | 39.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 19 | 31 | $2,635 | $799.18 | 30.3% |
About Linda Moody, NP
Linda Moody, NP is a Hospitalist healthcare provider based in Bristol, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2018. The National Provider Identifier (NPI) number assigned to this provider is 1235634361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Linda Moody, NP has received a total of $1,536 in payments from pharmaceutical and medical device companies, with $514.84 received in 2024. These payments were reported across 74 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,438).
As a Medicare-enrolled provider, Moody has provided services to 515 Medicare beneficiaries, totaling 896 services with total Medicare billing of $43,771. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Family
- Location Bristol, TN
- Active Since 03/29/2018
- Last Updated 12/04/2020
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1235634361
Products in Payments
- Arikayce (Drug) $333.67
- XERAVA (Drug) $262.42
- DALVANCE (Drug) $230.64
- ZERBAXA (Drug) $118.29
- DIFICID (Drug) $93.17
- DOVATO (Drug) $92.42
- Fetroja (Drug) $77.79
- PIFELTRO (Drug) $69.98
- AVYCAZ (Drug) $48.35
- TEFLARO (Drug) $32.44
- Kimyrsa (Drug) $28.01
- ZENPEP (Drug) $22.28
- RECARBRIO (Drug) $13.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Bristol
Stephanie Adams, D.o, D.O
Hospitalist — Payments: $622.97
Hospitalist $622.97
Dr. Mary Marquette, M.d, M.D
Hospitalist — Payments: $407.08
Hospitalist $407.08
Dr. Roshani Patel
Hospitalist — Payments: $164.38
Hospitalist $164.38
Dr. Hasmukh Patel, Md, MD
Hospitalist — Payments: $129.74
Hospitalist $129.74
Sarah Gach, Md, MD
Hospitalist — Payments: $128.60
Hospitalist $128.60
Mark Sah, Do, DO
Hospitalist — Payments: $72.06
Hospitalist $72.06